Evaluation of efficacy of steroid eye dropfor macular disease

JRCT ID: jRCTs041180160

Registered date:29/03/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: macula edema, neovascular eye disease
• Date of first enrollment: 19/12/2008
• Target sample size: 130
• Study type: Interventional
• Intervention(s): eye drop treatment

Outcome(s)

• Primary Outcome: macular thickness, visual acuity
• Secondary Outcome: safety

Key inclusion & exclusion criteria

• Age minimum: 20 years old
• Age maximum: 90 years old
• Gender: Both
• Include criteria: The patients with mean foveal thickness more than 300 micro meter.
• Exclude criteria: The patients who have history of elevation of intraocular pressure by using steroid drugs.

Related Information

• Primary Sponsor: Yamashita Hidetoshi